Award
NIH Reporter #5IK2CX002606-02
Examining ketamine effects on depression, neuroplasticity, and inflammation in Veterans with Parkinson's disease
Recipient
Veterans Affairs
Awarded
July 08, 2026
Identifier
5IK2CX002606-02
A VA-funded study investigating intravenous ketamine's effects on depression, neuroplasticity, and inflammation in Veterans with Parkinson's disease, focusing on safety and efficacy.
Description
This project involves a randomized, placebo-controlled study to examine the effects of intravenous ketamine on depression, neuroplasticity, and inflammation in Veterans with Parkinson's disease. The study aims to understand ketamine's mechanisms and potential as a treatment, with a focus on safety, tolerability, and efficacy. The project is funded by the VA and aligns with VA priorities for neuropsychiatric disorder research.